Abstract

BackgroundDetermining the shared and unique neoantigen profiles in cutaneous squamous cell carcinoma (cSCC) is critical to selecting immunotherapeutic approaches for improved prevention and treatment of cSCC. Nonmelanoma skin cancer, including...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call